Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Total Non-Current Liabilities: 2010-2020

Historic Total Non-Current Liabilities for OptimizeRx (OPRX) over the last 11 years, with FY2020 value amounting to $325533.0.

  • OptimizeRx's Total Non-Current Liabilities fell 2692.07% to $260614.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 million, marking a year-over-year decrease of 8770.74%. This contributed to the annual value of $325533.0 for FY2020, which is 9425.74% down from last year.
  • OptimizeRx's Total Non-Current Liabilities amounted to $325533.0 in FY2020, which was down 9425.74% from $5.7 million recorded in FY2019.
  • Over the past 5 years, OptimizeRx's Total Non-Current Liabilities peaked at $5.7 million during FY2019, and registered a low of $325533.0 during FY2020.
  • In the last 5 years, OptimizeRx's Total Non-Current Liabilities had a median value of $2.3 million in 2017 and averaged $2.4 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 13969.36% in 2019, then crashed by 9425.74% in 2020.
  • Annual analysis of 5 years shows OptimizeRx's Total Non-Current Liabilities stood at $1.4 million in 2016, then soared by 64.47% to $2.3 million in 2017, then increased by 4.8% to $2.4 million in 2018, then soared by 139.69% to $5.7 million in 2019, then tumbled by 94.26% to $325533.0 in 2020.
  • Its Total Non-Current Liabilities was $325533.0 in FY2020, compared to $5.7 million in FY2019 and $2.4 million in FY2018.